PL376744A1 - Tabletki farmaceutyczne zawierające tibolon i powłoczkę - Google Patents

Tabletki farmaceutyczne zawierające tibolon i powłoczkę

Info

Publication number
PL376744A1
PL376744A1 PL376744A PL37674403A PL376744A1 PL 376744 A1 PL376744 A1 PL 376744A1 PL 376744 A PL376744 A PL 376744A PL 37674403 A PL37674403 A PL 37674403A PL 376744 A1 PL376744 A1 PL 376744A1
Authority
PL
Poland
Prior art keywords
coating
tablets containing
pharmaceutical tablets
tibolone
containing tibolone
Prior art date
Application number
PL376744A
Other languages
English (en)
Inventor
Haan Pieter De
Lare Cornelis Elisabeth Johannus Van
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of PL376744A1 publication Critical patent/PL376744A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL376744A 2002-11-20 2003-11-13 Tabletki farmaceutyczne zawierające tibolon i powłoczkę PL376744A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42774002P 2002-11-20 2002-11-20
EP02079920 2002-11-20

Publications (1)

Publication Number Publication Date
PL376744A1 true PL376744A1 (pl) 2006-01-09

Family

ID=52340857

Family Applications (1)

Application Number Title Priority Date Filing Date
PL376744A PL376744A1 (pl) 2002-11-20 2003-11-13 Tabletki farmaceutyczne zawierające tibolon i powłoczkę

Country Status (11)

Country Link
EP (1) EP1565168A1 (pl)
JP (1) JP2006508144A (pl)
AU (1) AU2003298290A1 (pl)
BR (1) BR0316417A (pl)
CA (1) CA2505485A1 (pl)
MX (1) MXPA05005381A (pl)
NZ (1) NZ539715A (pl)
PL (1) PL376744A1 (pl)
RU (1) RU2005119197A (pl)
TW (1) TW200418525A (pl)
WO (1) WO2004045587A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1563833B1 (de) * 2004-02-06 2006-11-02 Helm AG Pharmazeutische Zubereitungen mit amorphem Tibolon
WO2005084682A1 (en) * 2004-03-08 2005-09-15 Pharmaceutical Services Inc. (Psi Nv.) Pharmaceutical composition comprising cyclodextrin complex of tibolone
CZ300465B6 (cs) * 2007-07-25 2009-05-27 Zentiva, A. S. Zpusob výroby komprimované farmaceutické formulace s obsahem tibolonu
HUE055164T2 (hu) 2016-05-04 2021-11-29 Novalon S A Cukoralkoholok alkalmazása Tobolon tartalmú készítményekben

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL123984A (en) * 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
DE69702985T2 (de) * 1997-09-23 2001-02-15 Akzo Nobel N.V., Arnheim/Arnhem Steroid enthaltende Dosierungsformen mit einer steroiddichten Umhüllung
CZ298703B6 (cs) * 1998-10-16 2007-12-27 N.V. Organon Vysoce cistý (7alfa, 17alfa)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-on se zvýšenou stabilitou
JP2002068965A (ja) * 2000-08-31 2002-03-08 Teikoku Hormone Mfg Co Ltd 単層糖衣錠及びその製造方法

Also Published As

Publication number Publication date
TW200418525A (en) 2004-10-01
NZ539715A (en) 2006-04-28
WO2004045587A1 (en) 2004-06-03
JP2006508144A (ja) 2006-03-09
CA2505485A1 (en) 2004-06-03
BR0316417A (pt) 2005-10-11
EP1565168A1 (en) 2005-08-24
MXPA05005381A (es) 2005-08-26
AU2003298290A1 (en) 2004-06-15
RU2005119197A (ru) 2006-02-10

Similar Documents

Publication Publication Date Title
TWI350184B (en) High drug load tablet
HUP0402293A3 (en) Orodispersible tablets containing fexofenadine, coated granules and process for its preparation
GB0229021D0 (en) Pharmaceutical pellets comprising tamsulosin and a process for making the same
ZA200500432B (en) Sustained-release tablet comprising reboxetine
IL165746A0 (en) Lasofoxifene tablet and its coating
AU137637S (en) A pharmaceutical tablet
IL146632A0 (en) Pharmaceutical tablets
AU137736S (en) A pharmaceutical tablet
HUP0500004A3 (en) Extended release pharmaceutical tablet of metformin
AU145547S (en) A tablet for example a pharmaceutical tablet
PL367262A1 (pl) Farmaceutyczna tabletka o wysokiej zawartości API(farmaceutycznej substancji czynnej)
PL376744A1 (pl) Tabletki farmaceutyczne zawierające tibolon i powłoczkę
AU145546S (en) A tablet for example a pharmaceutical tablet
HRP20050430A2 (en) Pharmaceutical tablets containing tibolone and a coating
AU155083S (en) Pharmaceutical packaging
AU155150S (en) Pharmaceutical packaging
HK1079124A (en) Pharmaceutical tablets containing tibolone and a coating
GB2383988B (en) Pill dispenser
AU153406S (en) A tablet
IL150614A0 (en) Tablet dispenser
GB0018663D0 (en) Coated tablets
IL147206A0 (en) Tablet dispenser
GB0105604D0 (en) Tablet dispenser
CA88762S (en) Pharmaceutical tablet
PL354856A1 (pl) Podstawa tabletu

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)